For these experiments, we pre-treated the VERO cells with a range of concentrations of DGAT-1 inhibitor A922500 (0.1–50 μM) for 2 hours, followed by infection with SARS-CoV-2 (MOI 0.01) for 24 hours in the presence of the inhibitor. Here, DGAT1 is linked to infection.